185 related articles for article (PubMed ID: 10197039)
1. Cytotoxics derived from distamycin A and congeners.
Cozzi P; Mongelli N
Curr Pharm Des; 1998 Jun; 4(3):181-201. PubMed ID: 10197039
[TBL] [Abstract][Full Text] [Related]
2. Distamycin A as stem of DNA minor groove alkylating agents.
Baraldi PG; Nûnez Mdel C; Espinosa A; Romagnoli R
Curr Top Med Chem; 2004; 4(2):231-9. PubMed ID: 14754456
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antitumor activity of new benzoheterocyclic derivatives of distamycin A.
Baraldi PG; Romagnoli R; Beria I; Cozzi P; Geroni C; Mongelli N; Bianchi N; Mischiati C; Gambari R
J Med Chem; 2000 Jul; 43(14):2675-84. PubMed ID: 10893305
[TBL] [Abstract][Full Text] [Related]
4. Recent outcome in the field of distamycin-derived minor groove binders.
Cozzi P
Farmaco; 2000 Mar; 55(3):168-73. PubMed ID: 10919073
[TBL] [Abstract][Full Text] [Related]
5. Distamycins: strategies for possible enhancement of activity and specificity.
Cortesi R; Esposito E
Mini Rev Med Chem; 2010 Mar; 10(3):217-30. PubMed ID: 20408803
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, DNA binding, cytotoxicity and sequence specificity of a series of imidazole-containing analogs of the benzoic acid mustard distamycin derivative tallimustine containing an alkylating group at the C-terminus.
Brooks N; Lee M; Wright SR; Woo S; Centioni S; Hartley JA
Anticancer Drug Des; 1997 Oct; 12(7):591-606. PubMed ID: 9365504
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and biological activity of hybrid compounds between uramustine and DNA minor groove binder distamycin A.
Baraldi PG; Romagnoli R; Guadix AE; Pineda de las Infantas MJ; Gallo MA; Espinosa A; Martinez A; Bingham JP; Hartley JA
J Med Chem; 2002 Aug; 45(17):3630-8. PubMed ID: 12166936
[TBL] [Abstract][Full Text] [Related]
8. A new class of cytotoxic DNA minor groove binders: alpha-halogenoacrylic derivatives of pyrrolecarbamoyl oligomers.
Cozzi P
Farmaco; 2001; 56(1-2):57-65. PubMed ID: 11347968
[TBL] [Abstract][Full Text] [Related]
9. Cinnamoyl nitrogen mustard derivatives of pyrazole analogues of tallimustine modified at the amidino moiety: design, synthesis, molecular modeling and antitumor activity studies.
Baraldi PG; Beria I; Cozzi P; Geroni C; Espinosa A; Gallo MA; Entrena A; Bingham JP; Hartley JA; Romagnoli R
Bioorg Med Chem; 2004 Jul; 12(14):3911-21. PubMed ID: 15210158
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxic alpha-halogenoacrylic derivatives of distamycin A and congeners.
Beria I; Baraldi PG; Cozzi P; Caldarelli M; Geroni C; Marchini S; Mongelli N; Romagnoli R
J Med Chem; 2004 May; 47(10):2611-23. PubMed ID: 15115402
[TBL] [Abstract][Full Text] [Related]
11. The effects of a benzoic acid mustard derivative of distamycin A (FCE 24517) and related minor groove-binding distamycin analogues on the activity of major groove-binding alkylating agents.
Coley HM; Mongelli N; D'Incalci M
Biochem Pharmacol; 1993 Feb; 45(3):619-26. PubMed ID: 8442762
[TBL] [Abstract][Full Text] [Related]
12. Hybrid molecules between distamycin A and active moieties of antitumor agents.
Baraldi PG; Preti D; Fruttarolo F; Tabrizi MA; Romagnoli R
Bioorg Med Chem; 2007 Jan; 15(1):17-35. PubMed ID: 17081759
[TBL] [Abstract][Full Text] [Related]
13. Benzoyl and cinnamoyl nitrogen mustard derivatives of benzoheterocyclic analogues of the tallimustine: synthesis and antitumour activity.
Baraldi PG; Romagnoli R; Giovanna Pavani M; del Carmen Nunez M; Bingham JP; Hartley JA
Bioorg Med Chem; 2002 May; 10(5):1611-8. PubMed ID: 11886822
[TBL] [Abstract][Full Text] [Related]
14. Distamycin derivatives as potential anticancer agents.
Cozzi P
IDrugs; 2001 May; 4(5):573-81. PubMed ID: 16012903
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, DNA binding, and biological evaluation of water-soluble hybrid molecules containing two pyrazole analogues of the alkylating cyclopropylpyrroloindole (CPI) subunit of the antitumor agent CC-1065 and polypyrrole minor groove binders.
Baraldi PG; Balboni G; Pavani MG; Spalluto G; Tabrizi MA; Clercq ED; Balzarini J; Bando T; Sugiyama H; Romagnoli R
J Med Chem; 2001 Aug; 44(16):2536-43. PubMed ID: 11472207
[TBL] [Abstract][Full Text] [Related]
16. The discovery of a new potential anticancer drug: a case history.
Cozzi P
Farmaco; 2003 Mar; 58(3):213-20. PubMed ID: 12620417
[TBL] [Abstract][Full Text] [Related]
17. Selective DNA interaction of the novel distamycin derivative FCE 24517.
Broggini M; Erba E; Ponti M; Ballinari D; Geroni C; Spreafico F; D'Incalci M
Cancer Res; 1991 Jan; 51(1):199-204. PubMed ID: 1859575
[TBL] [Abstract][Full Text] [Related]
18. Development of distamycin-related DNA binding anticancer drugs.
Marchini S; Broggini M; Sessa C; D'Incalci M
Expert Opin Investig Drugs; 2001 Sep; 10(9):1703-14. PubMed ID: 11772279
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and biological evaluation of DNA sequence and minor groove selective alkylating agents.
Lee M; Rhodes AL; Wyatt MD; Forrow S; Hartley JA
Anticancer Drug Des; 1993 Jun; 8(3):173-92. PubMed ID: 8517912
[TBL] [Abstract][Full Text] [Related]
20. Alpha-bromoacryloyl derivative of distamycin A (PNU 151807): a new non-covalent minor groove DNA binder with antineoplastic activity.
Marchini S; Cirò M; Gallinari F; Geroni C; Cozzi P; D'Incalci M; Broggini M
Br J Cancer; 1999 Jun; 80(7):991-7. PubMed ID: 10362106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
